Uterine Carcinosarcoma in A Postmenopausal Woman: A Rare Case Report
- 21 Downloads
Uterine carcinosarcomas are rare tumors accounting for about 2–4% of all uterine cancer and with a poor prognosis with 5-year survival of only 21–39%. These are highly aggressive tumors and usually diagnosed with distant metastasis at the initial diagnosis. The origin of this tumor has been studied extensively, and these are now believed to be metaplastic carcinomas. The treatment of the early-stage disease is surgery, and in the late stages the role of adjuvant chemotherapy and radiotherapy is debated. We report here a case of the early-stage uterine carcinosarcoma in a postmenopausal woman.
KeywordsUterine carcinosarcomas Postmenopausal Aggressive tumors Mesodermal mixed tumor
Compliance with Ethical Standards
Conflict of interest
We declare that this manuscript is original, and it has not been published anywhere before and is not currently being considered for publication elsewhere. We also confirm that the authors do not have any conflict of interest associated with publication of this work, and no significant financial support for this work has been received to influence the outcome. The manuscript is read and approved, and consent is given by all the authors. We give our permission to reproduce any material of the article.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
- 3.Galaal K, van der Heijden E, Godfrey K, Naik R, Kucukmetin A, Bryant A, et al. Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma. Cochrane Database Syst Rev. 2013;28(2):CD006812.Google Scholar